Evidence map›Paper›PMID 23824793›Full record

ArticleJournal of virology2013

CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Nicholas Francella, Sarah E Gwyn, Yanjie Yi, Bing Li, Peng Xiao, Sarah T C Elliott, Alexandra M Ortiz, James A Hoxie, Mirko Paiardini, Guido Silvestri and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nicholas FrancellaDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Sarah E Gwyn
Yanjie Yi
Bing Li
Peng Xiao
Sarah T C Elliott
Alexandra M Ortiz
James A Hoxie
Mirko Paiardini
Guido Silvestri
Cynthia A Derdeyn
Ronald G Collman
Emory University · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYSR37AI066998 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2011 to 2020
$7.7M
Role of V1V2 in HIV transmission and pathogenesisR01AI058706 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DERDEYN, CYNTHIA ANN · 2004 to 2016
$6.7M
HIV: gp120, Chemokine Receptors &Macrophage ActivationR01MH061139 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1999 to 2015
$5.2M
Studies of Natural SIV Infection of Sooty MangabeysR01AI066998 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SILVESTRI, GUIDO · 2006 to 2010
$3.5M
Entry Coreceptor Use & Target Cell Tropism in Nonpathogenic SIV InfectionR56AI091516 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 2011 to 2011
$449k
NCI NIH HHS P30 CA016520NCRR NIH HHS P51 RR000165NCRR NIH HHS P51-RR000165NIAID NIH HHS AI066998NIAID NIH HHS AI091516NIAID NIH HHS P30 AI045008NIAID NIH HHS P30-AI045008NIAID NIH HHS R01 AI058706NIAID NIH HHS R01 AI066998NIAID NIH HHS R37 AI066998NIAID NIH HHS R56 AI091516NIAID NIH HHS T32 AI007632NIAID NIH HHS T32-AI007632NIH HHS P51 OD011132NIH HHS P51-OD011132NIMH NIH HHS MH61139NIMH NIH HHS R01 MH061139
6 · The paper itself

Abstract

CD4(+) T cells rather than macrophages are the principal cells infected by human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) in vivo. Macrophage tropism has been linked to the ability to enter cells through CCR5 in conjunction with limiting CD4 levels, which are much lower on macrophages than on T cells. We recently reported that rhesus macaques (RM) experimentally depleted of CD4(+) T cells before SIV infection exhibit extensive macrophage infection as well as high chronic viral loads and rapid progression to AIDS. Here we show that early-time-point and control Envs were strictly CD4 dependent but that, by day 42 postinfection, plasma virus of CD4(+) T cell-depleted RM was dominated by Envs that mediate efficient infection using RM CCR5 independently of CD4. Early-time-point and control RM Envs were resistant to neutralization by SIV-positive (SIV(+)) plasma but became sensitive if preincubated with sCD4. In contrast, CD4-independent Envs were highly sensitive to SIV(+) plasma neutralization. However, plasma from SIV-infected CD4(+) T cell-depleted animals lacked this CD4-inducible neutralizing activity and failed to neutralize any Envs regardless of sCD4 pre-exposure status. Enhanced sensitivity of CD4-independent Envs from day 42 CD4(+) T cell-depleted RM was also seen with monoclonal antibodies that target both known CD4-inducible and other Env epitopes. CD4 independence and neutralization sensitivity were both conferred by Env amino acid changes E84K and D470N that arose independently in multiple animals, with the latter introducing a potential N-linked glycosylation site within a predicted CD4-binding pocket of gp120. Thus, the absence of CD4 T cells results in failure to produce antibodies that neutralize CD4-independent Envs and CD4-pretriggered control Envs. In the absence of this constraint and with a relative paucity of CD4(+) target cells, widespread macrophage infection occurs in vivo accompanied by emergence of variants carrying structural changes that enable entry independently of CD4.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCD4 AntigensCD4-Positive T-LymphocytesGene Products, envHost-Pathogen InteractionsHumansLymphocyte DepletionMacaca mulattaMolecular Sequence DataSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTime FactorsViral TropismVirus InternalizationAntibodies, NeutralizingAntibodies, ViralCD4 AntigensGene Products, env

Identifiers

PMID23824793
PMCPMC3754144
OpenAlexW1965495859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.